BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23376230)

  • 1. From clinical description, to in vitro and animal studies, and backward to patients: oxidative stress and mitochondrial dysfunction in Fanconi anemia.
    Pagano G; Talamanca AA; Castello G; d'Ischia M; Pallardó FV; Petrović S; Porto B; Tiano L; Zatterale A
    Free Radic Biol Med; 2013 May; 58():118-25. PubMed ID: 23376230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of mitochondrial dysfunction and impaired ROS detoxifying machinery in Fanconi anemia cells.
    Kumari U; Ya Jun W; Huat Bay B; Lyakhovich A
    Oncogene; 2014 Jan; 33(2):165-72. PubMed ID: 23318445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial dysfunction in some oxidative stress-related genetic diseases: Ataxia-Telangiectasia, Down Syndrome, Fanconi Anaemia and Werner Syndrome.
    Pallardó FV; Lloret A; Lebel M; d'Ischia M; Cogger VC; Le Couteur DG; Gadaleta MN; Castello G; Pagano G
    Biogerontology; 2010 Aug; 11(4):401-19. PubMed ID: 20237955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress as a multiple effector in Fanconi anaemia clinical phenotype.
    Pagano G; Degan P; d'Ischia M; Kelly FJ; Nobili B; Pallardó FV; Youssoufian H; Zatterale A
    Eur J Haematol; 2005 Aug; 75(2):93-100. PubMed ID: 16000125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fanconi anemia (FA) and crosslinker sensitivity: Re-appraising the origins of FA definition.
    Pagano G; d'Ischia M; Pallardó FV
    Pediatr Blood Cancer; 2015 Jul; 62(7):1137-43. PubMed ID: 25732180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow cell transcripts from Fanconi anaemia patients reveal in vivo alterations in mitochondrial, redox and DNA repair pathways.
    Pagano G; Talamanca AA; Castello G; d'Ischia M; Pallardó FV; Petrović S; Porto B; Tiano L; Zatterale A
    Eur J Haematol; 2013 Aug; 91(2):141-51. PubMed ID: 23646927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress in Fanconi anaemia: from cells and molecules towards prospects in clinical management.
    Pagano G; Talamanca AA; Castello G; Pallardó FV; Zatterale A; Degan P
    Biol Chem; 2012 Jan; 393(1-2):11-21. PubMed ID: 22628295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining.
    Escarceller M; Buchwald M; Singleton BK; Jeggo PA; Jackson SP; Moustacchi E; Papadopoulo D
    J Mol Biol; 1998 Jun; 279(2):375-85. PubMed ID: 9642044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3R coordination by Fanconi anemia proteins.
    Macé G; Bogliolo M; Guervilly JH; Dugas du Villard JA; Rosselli F
    Biochimie; 2005 Jul; 87(7):647-58. PubMed ID: 15935541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular basis of Fanconi's anemia].
    Digweed M
    Klin Padiatr; 1999; 211(4):192-7. PubMed ID: 10472548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fanconi anaemia proteins: major roles in cell protection against oxidative damage.
    Pagano G; Youssoufian H
    Bioessays; 2003 Jun; 25(6):589-95. PubMed ID: 12766948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermediate DNA repair activity associated with the 322delG allele of the fanconi anemia complementation group C gene.
    Donahue SL; Lundberg R; Campbell C
    J Mol Biol; 2004 Oct; 342(5):1443-55. PubMed ID: 15364573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway.
    Mosedale G; Niedzwiedz W; Alpi A; Perrina F; Pereira-Leal JB; Johnson M; Langevin F; Pace P; Patel KJ
    Nat Struct Mol Biol; 2005 Sep; 12(9):763-71. PubMed ID: 16116434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.
    Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM
    J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Fanconi anaemia/BRCA pathway.
    D'Andrea AD; Grompe M
    Nat Rev Cancer; 2003 Jan; 3(1):23-34. PubMed ID: 12509764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ROMO1 regulates RedOx states and serves as an inducer of NF-κB-driven EMT factors in Fanconi anemia.
    Shyamsunder P; Verma RS; Lyakhovich A
    Cancer Lett; 2015 May; 361(1):33-8. PubMed ID: 25687884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.
    Xie Y; de Winter JP; Waisfisz Q; Nieuwint AW; Scheper RJ; Arwert F; Hoatlin ME; Ossenkoppele GJ; Schuurhuis GJ; Joenje H
    Br J Haematol; 2000 Dec; 111(4):1057-64. PubMed ID: 11167740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Fanconi anemia pathway promotes DNA glycosylase-dependent excision of interstrand DNA crosslinks.
    Macé-Aimé G; Couvé S; Khassenov B; Rosselli F; Saparbaev MK
    Environ Mol Mutagen; 2010 Jul; 51(6):508-19. PubMed ID: 20120016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interplay of Fanconi anemia proteins in the DNA damage response.
    Wang X; D'Andrea AD
    DNA Repair (Amst); 2004; 3(8-9):1063-9. PubMed ID: 15279794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.